Ambalal Sarabhai Enterprises’ arm clears USFDA inspection for GMP compliance

17 Feb 2020 Evaluate

Ambalal Sarabhai Enterprises’ wholly owned subsidiary -- Synbiotics has successfully cleared the United States Food and Drug Administration (USFDA) inspection consecutively 5th time for GMP compliance without any regulatory actions.

Ambalal Sarabhai Enterprises is engaged in manufacturing and marketing of pharmaceutical products, bulk drugs, industrial chemicals, detergents, toiletries, electronics, engineering products, paper, glass and plastic containers and packaging materials.

Ambalal Sarabhai Ent Share Price

27.75 -0.03 (-0.11%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×